Harrow Health, Inc.

HROW· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$39.09+0.83%

2026-08-03

Financials

Valuation Metrics

Harrow Health, Inc.'s Market Cap is $1.46B. At end of 2025 it was $1.80B. Ranked #2264 of 3,112 in US market (top 73%), #902 of 1,445 on NASDAQ (top 62%), #168 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 62%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.46B	US#2,264/3,112 Sec#168/269
Revenue	$269M	US#2,601/3,112 Sec#103/269
Net Income	$-15M	US—/3,112 Sec—/269
Total Assets	$420M	US#2,809/3,112 Sec#179/269
Net Assets	$29M	US#2,968/3,112 Sec#250/269
Value
P/B	50.76x	US#2,928/3,112 Sec#249/269
P/S	5.42x	US#2,327/3,112 Sec#84/269
EV/EBITDA	52.85x	US#2,363/3,112 Sec#80/269
FCF Yield	0.98%	US#2,138/3,112 Sec#77/269
Profitability
ROE	-52.12%	US#2,750/3,112 Sec#178/269
ROA	-3.57%	US#2,466/3,112 Sec#89/269
Op. Margin	10.47%	US#1,591/3,112 Sec#68/269
Revenue Growth	-7.58%	US#2,602/3,112 Sec#142/269
Financial Health
Debt Ratio	1362.75%	US#2,848/3,112 Sec#254/269
Total Debt	$301M	US#2,037/3,112 Sec#75/269
FCF	$14M	US#2,181/3,112 Sec#79/269
Cash	$95M	US#2,248/3,112 Sec#183/269
Current Ratio	2.48x	US#1,000/3,112 Sec#211/269
Net Debt/EBITDA	6.55x	US#2,217/3,112 Sec#88/269
Performance
1Y Return	25.17%	US#1,554/3,112 Sec#170/269
1M Return	-8.54%	US#2,514/3,112 Sec#152/269
From 52W High	-28.73%	US#2,117/3,112 Sec#157/269
1Y MDD	-47.03%	US#2,274/3,112 Sec#175/269
Trading
Volume	394,294 shares	US#2,230/3,112 Sec#218/269
Trading Value	$15M	US#2,124/3,112 Sec#165/269
Per Share
EPS	$-0.14	US—/3,112 Sec—/269
BPS	$1.43	US#2,572/3,112 Sec#190/269